Your browser doesn't support javascript.
loading
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).
Casadei-Gardini, Andrea; Montagnani, Francesco; Casadei, Chiara; Arcadipane, Francesca; Andrikou, Kalliopi; Aloi, Deborah; Prete, Alessandra Anna; Zampino, Maria Giulia; Argentiero, Antonella; Pugliese, Giuseppe; Martini, Stefania; Iorio, Giuseppe Carlo; Scartozzi, Mario; Mistrangelo, Massimiliano; Fornaro, Lorenzo; Cassoni, Paola; Marisi, Giorgia; Dell'Acqua, Veronica; Ravenda, Paola Simona; Lonardi, Sara; Silvestris, Nicola; De Bari, Berardino; Ricardi, Umberto; Cascinu, Stefano; Franco, Pierfrancesco.
Affiliation
  • Casadei-Gardini A; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Montagnani F; Oncology Department, SOC Oncology, ASL (Health Local Authority), Biella, Italy.
  • Casadei C; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Arcadipane F; Department of Oncology, Radiation Oncology, AOU Città della Salute e della Scienza, Turin, Italy.
  • Andrikou K; Department of Hematology and Oncology, University of Modena and Reggio Emilia, Modena, Italy.
  • Aloi D; Radiation Oncology Department, Centre Hospitalier Régional Universitaire "Jean Minjoz", Besançon Cedex, France.
  • Prete AA; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.
  • Zampino MG; Department of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I University Hospital, Rome, Italy.
  • Argentiero A; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
  • Pugliese G; Medical Oncology Unit, Cancer Institute Giovanni Paolo II, Bari, Italy.
  • Martini S; Department of Hematology and Oncology, University of Modena and Reggio Emilia, Modena, Italy.
  • Iorio GC; Department of Oncology, Radiation Oncology, University of Turin, Turin, Italy.
  • Scartozzi M; Department of Oncology, Radiation Oncology, University of Turin, Turin, Italy.
  • Mistrangelo M; Department of Medical Oncology, University of Cagliari, Cagliari, Italy.
  • Fornaro L; Department of Surgical Sciences, University of Turin, Turin, Italy.
  • Cassoni P; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana University, Pisa, Italy.
  • Marisi G; Department of Medical Sciences, Pathology Unit, University of Turin, Turin, Italy.
  • Dell'Acqua V; Biosciences Laboratory, Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Ravenda PS; Department of Radiotherapy, IRCCS, European Institute of Oncology, Milan, Italy.
  • Lonardi S; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
  • Silvestris N; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.
  • De Bari B; Department of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I University Hospital, Rome, Italy.
  • Ricardi U; Radiation Oncology Department, Centre Hospitalier Régional Universitaire "Jean Minjoz", Besançon Cedex, France.
  • Cascinu S; Department of Oncology, Radiation Oncology, AOU Città della Salute e della Scienza, Turin, Italy.
  • Franco P; Department of Hematology and Oncology, University of Modena and Reggio Emilia, Modena, Italy.
Cancer Manag Res ; 11: 3631-3642, 2019.
Article in En | MEDLINE | ID: mdl-31118786

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Manag Res Year: 2019 Document type: Article Affiliation country: Italy Country of publication: New Zealand

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Manag Res Year: 2019 Document type: Article Affiliation country: Italy Country of publication: New Zealand